AgeX Therapeutics Inc (AMEX:AGE) price closed lower on Friday, November 17, dropping -26.65% below its previous close.
A look at the daily price movement shows that the last close reads $0.59, with intraday deals fluctuated between $0.36 and $0.52. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.00 and 52-week low of $0.37. The stock subtracted -34.02% on its value in the past month.
AgeX Therapeutics Inc, which has a market valuation of $16.33 million, is expected to release its quarterly earnings report Nov 14, 2023.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give AGE a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that AGE’s price is at present -29.94% off the SMA20 and -36.81% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 28.17, with weekly volatility standing at 15.82%. The indicator jumps to 10.01% when calculated based on the past 30 days. AgeX Therapeutics Inc (AMEX:AGE)’s beta value is holding at 1.66, while the average true range (ATR) indicator is currently reading 0.06.
An analysis of the AgeX Therapeutics Inc (AMEX:AGE) stock in terms of its daily trading volume indicates that the 3-month average is 17.40K. However, this figure increases on the past 10-day timeline to an average of 1.12 million.
Current records show that the company has 37.95M in outstanding shares. The insiders’ percentage holdings are 43.47% of outstanding shares while the percentage share held by institutions stands at 12.96%. The stats also highlight that short interest as of Oct 30, 2023, stood at 92410.0 shares, which puts the short ratio at the time at 10.23. From this we can glean that short interest is 0.24% of company’s current outstanding shares. Notably, we see that shares short in October fall slightly given the previous month’s figure stood at 96660.0. But the -22.05% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.